[揭示尼塞利亚淋病生存率:遗传变异性,发病性和抗菌药物耐药性]

B L Shaskolskiy1,2, I D Kandinov1, D A Gryadunov1

  • 1Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia.

Molekuliarnaia biologiia
|February 19, 2025
PubMed
概括

尼塞利亚淋病在全球引起数百万次感染,并迅速发展出抗菌素耐药性. 本综述涵盖了它的发病,免疫逃避,耐药性机制以及不断发展的诊断和治疗策略.